Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Malyukova A, Ujvari D, Yektaei-Karin E, Zovko A, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Tamai M, Nguyen TTT, Akahane K, Inukai T, Stenke L, Salamon D.
Malyukova A, et al. Among authors: wallvik j.
Cell Death Dis. 2021 Sep 25;12(10):875. doi: 10.1038/s41419-021-04154-0.
Cell Death Dis. 2021.
PMID: 34564697
Free PMC article.